BFA
GILD icon

Benedict Financial Advisors’s Gilead Sciences GILD Stock Holding History

Benedict Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Buy
11,812
+28
+0.2% +$3.69K 0.29% 94
2026
Q1 		$1.64M Sell
11,784
-318
-3% -$44.5K 0.34% 91
2025
Q4 		$1.49M Sell
12,102
-312
-3% -$37.9K 0.31% 91
2025
Q3 		$1.38M Buy
12,414
+43
+0.3% +$4.89K 0.3% 92
2025
Q2 		$1.37M Buy
12,371
+45
+0.4% +$4.79K 0.31% 86
2025
Q1 		$1.38M Sell
12,326
-72
-0.6% -$7.43K 0.32% 87
2024
Q4 		$1.15M Buy
12,398
+53
+0.4% +$4.77K 0.28% 89
2024
Q3 		$1.04M Sell
12,345
-168
-1% -$12.8K 0.24% 93
2024
Q2 		$859K Sell
12,513
-34
-0.3% -$2.27K 0.22% 94
2024
Q1 		$919K Buy
12,547
+20
+0.2% +$1.54K 0.23% 95
2023
Q4 		$1.01M Buy
12,527
+66
+0.5% +$5.14K 0.28% 90
2023
Q3 		$934K Buy
12,461
+53
+0.4% +$4.08K 0.27% 90
2023
Q2 		$956K Buy
12,408
+50
+0.4% +$3.99K 0.26% 92
2023
Q1 		$1.03M Buy
12,358
+62
+0.5% +$5.13K 0.29% 90
2022
Q4 		$1.06M Sell
12,296
-2
-0% -$158 0.31% 85
2022
Q3 		$759K Sell
12,298
-1,778
-13% -$112K 0.24% 92
2022
Q2 		$870K Sell
14,076
-1,026
-7% -$63.5K 0.26% 92
2022
Q1 		$898K Sell
15,102
-2,303
-13% -$147K 0.24% 93
2021
Q4 		$1.26M Sell
17,405
-273
-2% -$18.8K 0.33% 87
2021
Q3 		$1.24M Sell
17,678
-306
-2% -$21.5K 0.34% 88
2021
Q2 		$1.24M Sell
17,984
-1,153
-6% -$77K 0.34% 88
2021
Q1 		$1.24M Sell
19,137
-1,020
-5% -$65.8K 0.36% 84
2020
Q4 		$1.17M Sell
20,157
-116
-0.6% -$7K 0.42% 71
2020
Q3 		$1.28M Sell
20,273
-450
-2% -$31.2K 0.49% 66
2020
Q2 		$1.59M Buy
20,723
+90
+0.4% +$6.9K 0.66% 51
2020
Q1 		$1.54M Sell
20,633
-2,457
-11% -$170K 0.73% 49
2019
Q4 		$1.5M Sell
23,090
-2,270
-9% -$148K 0.58% 55
2019
Q3 		$1.61M Sell
25,360
-125
-0.5% -$8.17K 0.66% 52
2019
Q2 		$1.72M Sell
25,485
-172
-0.7% -$11.3K 0.72% 49
2019
Q1 		$1.67M Sell
25,657
-383
-1% -$25.5K 0.72% 50
2018
Q4 		$1.63M Buy
26,040
+289
+1% +$20.2K 0.8% 46
2018
Q3 		$1.99M Buy
25,751
+278
+1% +$21K 0.89% 44
2018
Q2 		$1.8M Buy
25,473
+673
+3% +$47.5K 0.89% 42
2018
Q1 		$1.87M Buy
24,800
+459
+2% +$36.5K 0.94% 43
2017
Q4 		$1.74M Buy
24,341
+361
+2% +$27.4K 0.84% 45
2017
Q3 		$1.94M Buy
23,980
+313
+1% +$23.9K 1% 39
2017
Q2 		$1.75M Buy
23,667
+2,922
+14% +$194K 0.91% 44
2017
Q1 		$1.41M Buy
20,745
+4,454
+27% +$313K 0.77% 46
2016
Q4 		$1.17M Buy
16,291
+6,902
+74% +$513K 0.67% 49
2016
Q3 		$733K Buy
+9,389
New +$763K 0.43% 65

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Benedict Financial Advisors's GILD Position: Q2 2026 in Review

Benedict Financial Advisors increased its Gilead Sciences (GILD) stake by 0.24% in Q2 2026, buying an estimated $3.69K and bringing the position to 11,812 shares worth $1.49M. The position accounts for 0.29% of the portfolio, ranked #94.

Benedict Financial Advisors first reported a position in GILD in Q3 2016 and has held it in 40 quarters since. The position peaked at $1.99M in Q3 2018. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Benedict Financial Advisors held 11,812 shares of Gilead Sciences worth $1.49M as of Q2 2026.
  • Benedict Financial Advisors bought 28 Gilead Sciences shares in Q2 2026, an estimated $3.69K.
  • Gilead Sciences made up 0.29% of Benedict Financial Advisors's portfolio in Q2 2026, its #94 holding.
  • Benedict Financial Advisors first reported a position in Gilead Sciences in Q3 2016 and has held it in 40 quarters since.
  • Benedict Financial Advisors's Gilead Sciences position peaked at $1.99M in Q3 2018.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Benedict Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.